Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
HCCF
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by dardadog: [QB] 2004-06-28 16:00:09 HEE Corporation Announces Update on Trial Treatment *** Business Editors HUTCHINSON, Kan.--(BUSINESS WIRE)--HCCF-- HEE Corporation - (OTC - PK - HCCF) would like to provide an update on Ron Brooks and Stan Casad's treatments. They have now completed 4 days of treatments out of the eight weeks and the results to date are as follows: Both Ron Brooks's and Stan Casad's sugar levels have dropped substantially over the first four days the readings at 8:00 am each day are as follows: -0- *T Ron Brooks Stan Casad Arrival 231 215 Thursday June 24th Day 1 147 187 Friday June 25th Day 2 137 157 Saturday June 26th Day 3 141 198 Sunday June 27th Day 4 110 134 Monday June 28th *T Normal blood sugar levels for an adult male is approximately 90. Mr. Brooks had stopped taking his medication, for the control of his Type II Diabetes, upon his arrival. Prior to his arrival Mr. Brooks had been taking 45 Mg of Actos once a day and 12 Mg of Glyburide four times a day with food 30 minutes before eating to try and control the blood sugar in his body. Stan Casad had been managing his Diabetes through diet and other means and was never on any medication. This is incredibly significant as anyone with Type II Diabetes knows that up until now, the only effective way of controlling it was through medication usually using insulin. Both gentlemen are very encouraged and excited by the initial results and look forward to completing the treatment cycle. Mr. Brooks and Mr. Casad are under the personal care of the doctor who developed this incredible medical breakthrough treatment. Keep posted to our website for future developments on the treatment and further updates. ABOUT HEE CORPORATION The HEE Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. HEE has acquired the worldwide distribution rights for this diabetic treatment. Just in the United States type II Diabetes has reached epidemic levels with 18.2 million confirmed cases and an estimated 5 million cases that are undiagnosed. Hundreds of billions of dollars world wide is spent each year on the treatment of this disease. For more information about the Company contact Shannon @620-663-3333 or visit our web site at [URL=http://www.hee-corp.com.]www.hee-corp.com.[/URL] NOTE: Safe Harbor for Forward-Looking Statements--Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation and risk inherent in the company's international operations. KEYWORD: KANSAS INDUSTRY KEYWORD: CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD MEDICAL EDUCATION CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD CONSUMER/HOUSEHOLD PRODUCT SOURCE: HEE Corporation CONTACT INFORMATION: HEE Corporation Shannon Meyer, 620-663-3333 [URL=http://www.hee-corp.com]www.hee-corp.com[/URL] [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2